The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 open label trial of intraperitoneal paclitaxel (IPP) in combination with intravenous cisplatin (C) and oral capecitabine (X) in patients with advanced gastric cancer and peritoneal metastases.
 
Sina Vatandoust
No Relationships to Disclose
 
Tim F Bright
No Relationships to Disclose
 
M Nazim Abbas
No Relationships to Disclose
 
Amitesh Chandra Roy
No Relationships to Disclose
 
David I. Watson
No Relationships to Disclose
 
Susan S H Gan
No Relationships to Disclose
 
Alex Scott-Hoy
No Relationships to Disclose
 
Jeff A Bull
No Relationships to Disclose
 
Christos Stelios Karapetis
Honoraria - MSD
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Roche